ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,671.26
0.41%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. NeoGenomics Inc (NEO)

  7. NeoGenomics Inc (NEO) Noticias

NEO NeoGenomics Inc

14.14
0.29 (2.09%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NeoGenomics Inc NEO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.29 2.09% 14.14 23:00:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
13.91 13.68 14.35 14.14 13.85
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202406:05BWNeoGenomics Announces Senior Leadership Promotions
09/4/202406:00BWNeoGenomics to Report First Quarter 2024 Financial Results..
27/3/202407:30BWNeoGenomics Showcases Commitment to Transforming Cancer..
20/3/202406:00BWNeoGenomics Releases Inaugural Environmental, Social, and..
06/3/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:33EDGAR2Form 144 - Report of proposed sale of securities
01/3/202406:05BWNeoGenomics to Participate in the TD Cowen 44th Annual..
27/2/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:15EDGAR2Form 8-K/A - Current report: [Amend]
20/2/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202415:06EDGAR2Form 8-K - Current report
20/2/202415:05BWNeoGenomics Reports Fourth Quarter and Full Year 2023..
20/2/202404:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
15/2/202415:26EDGAR2Form 144 - Report of proposed sale of securities
14/2/202409:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202414:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202406:05BWNeoGenomics Signs Working with Cancer Pledge in Support of..
30/1/202406:05BWNeoGenomics to Report Fourth Quarter and Full Year 2023..
03/1/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202406:05BWNeoGenomics to Participate in the 42nd Annual J.P. Morgan..
11/12/202318:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202315:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:25EDGAR2Form 144 - Report of proposed sale of securities
06/11/202315:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202315:18EDGAR2Form 8-K - Current report
03/10/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202316:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:03EDGAR2Form 8-K - Current report
01/8/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202317:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/7/202318:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/7/202317:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/6/202315:21EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
NEO
NeoGenomics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados